| 000 | 01516 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513211851.0 | ||
| 264 | 0 | _c20000811 | |
| 008 | 200008s 0 0 eng d | ||
| 022 | _a0378-7346 | ||
| 024 | 7 |
_a10.1159/000010254 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShimano, M | |
| 245 | 0 | 0 |
_aActivation of Ca2+-activated K+ channels in human myometrium by nitric oxide. _h[electronic resource] |
| 260 |
_bGynecologic and obstetric investigation _c2000 |
||
| 300 |
_a249-54 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aArginine _xpharmacology |
| 650 | 0 | 4 |
_aCalcium _xpharmacology |
| 650 | 0 | 4 | _aElectric Conductivity |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsosorbide Dinitrate _xpharmacology |
| 650 | 0 | 4 |
_aLipopolysaccharides _xpharmacology |
| 650 | 0 | 4 |
_aMyometrium _xphysiology |
| 650 | 0 | 4 |
_aNG-Nitroarginine Methyl Ester _xpharmacology |
| 650 | 0 | 4 |
_aNitric Oxide _xpharmacology |
| 650 | 0 | 4 |
_aNitric Oxide Donors _xpharmacology |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPotassium Channels _xdrug effects |
| 650 | 0 | 4 | _aPregnancy |
| 700 | 1 | _aNakaya, Y | |
| 700 | 1 | _aFukui, R | |
| 700 | 1 | _aKamada, M | |
| 700 | 1 | _aHamada, Y | |
| 700 | 1 | _aMaeda, K | |
| 700 | 1 | _aAono, T | |
| 773 | 0 |
_tGynecologic and obstetric investigation _gvol. 49 _gno. 4 _gp. 249-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000010254 _zAvailable from publisher's website |
| 999 |
_c10780243 _d10780243 |
||